Cleerly LABS vs FibriCheck
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify atherosclerosis, characterize plaque, and detect stenosis. This tool is ideal for cardiologists and radiologists seeking detailed insights into structural coronary artery disease and its progression for personalized heart disease management.
View Cleerly LABS →Choose FibriCheck if…
Choose FibriCheck if you need a convenient, smartphone-based solution for continuous or on-demand heart rhythm monitoring to detect and track arrhythmias like Atrial Fibrillation. This app is best suited for patients and healthcare providers focused on remote patient monitoring and early detection of rhythm disturbances outside of a clinical setting.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | FibriCheck |
|---|---|---|
| Pricing | Varies | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Cloud, On-premise | Cloud-based (private cloud). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckFibriCheck is designed for direct patient use via a smartphone app, offering a highly accessible and intuitive experience for heart rhythm monitoring. Cleerly LABS, while likely efficient for trained medical professionals, is integrated into a complex clinical imaging workflow, making its 'usability' different in scope and target audience.
Clinical Value
Cleerly LABSCleerly LABS provides comprehensive, quantitative analysis of coronary plaque and stenosis from CCTA, offering deep insights for personalized heart disease management and prevention of major cardiac events. While FibriCheck offers valuable arrhythmia detection, Cleerly's detailed diagnostic capabilities represent a more profound clinical advancement in understanding and managing complex cardiovascular disease.
Pricing & Value
FibriCheckFibriCheck offers a low-cost, subscription-based model, making continuous heart rhythm monitoring highly accessible and affordable for individual patients. Cleerly LABS is a high-cost, per-analysis diagnostic tool, which, while justified by its specialized output, represents a significantly higher financial barrier for widespread or ongoing use.
Enterprise Readiness
Cleerly LABSCleerly LABS explicitly details integration with core hospital systems like PACS, RIS, and EHR via an on-site proxy, which is critical for seamless adoption within existing radiology and cardiology department workflows. FibriCheck also offers enterprise solutions for providers, but Cleerly's specific integration points for diagnostic imaging give it a slight edge in traditional hospital enterprise readiness.
Innovation
Cleerly LABSCleerly LABS represents a significant innovation in diagnostic imaging by moving beyond traditional stenosis assessment to provide comprehensive, AI-powered plaque characterization and disease progression tracking. FibriCheck's use of smartphone PPG for arrhythmia detection is innovative in its accessibility, but the underlying technology is less novel compared to Cleerly's advanced CCTA analysis.
Support & Docs
FibriCheckFibriCheck provides a publicly accessible 'Help Center' with user manuals, FAQs, and contact options for both individuals and healthcare providers, indicating readily available support resources. While Cleerly, as an enterprise solution, would have support, its documentation and support channels are not as explicitly or publicly detailed for end-users in the provided information or web searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | FibriCheck |
|---|---|---|
| Name | Cleerly LABS | FibriCheck |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Primary Technology/Method | AI-powered CCTA image analysis | Smartphone camera-based PPG technology for heart rhythm measurement, AI-powered algorithm for arrhythmia detection and analysis |
| Key Detection/Analysis | Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module) | Arrhythmia detection and analysis, Detection of Atrial Fibrillation (AFib) and other arrhythmias |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and FibriCheck.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or FibriCheck
Backers
Who funded each tool's parent company.